Cutaneous Larva Migrans.

IF 4.2 Q3 Pharmacology, Toxicology and Pharmaceutics
A. Leung, B. Barankin, K. Hon
{"title":"Cutaneous Larva Migrans.","authors":"A. Leung, B. Barankin, K. Hon","doi":"10.2174/1872213X11666170110162344","DOIUrl":null,"url":null,"abstract":"BACKGROUND\nCutaneous larva migrans is one of the most common skin diseases reported in travelers returning from tropical regions. Western physicians, however, are often not familiar of this condition.\n\n\nOBJECTIVE\nTo review in depth the epidemiology, pathophysiology, clinical manifestations, complications, and treatment of cutaneous larva migrans.\n\n\nMETHODS\nA PubMed search was completed in Clinical Queries using the key term \"cutaneous larva migrans\". The search included meta-analyses, randomized controlled trials, clinical trials, and reviews. Patents were searched using the key term \"cutaneous larva migrans\" from www.google.com/patents, www.uspto.gov, and www.freepatentsonline.com.\n\n\nRESULTS\nCutaneous larva migrans is a zoonotic infestation caused by penetration and migration in the epidermis of filariform larva of different kinds of animal hookworms through contact with feces of infected animals. Cutaneous larva migrans is endemic in tropical and subtropical regions. Clinically, cutaneous larva migrans is characterized by an intensely pruritic erythematous migrating tortuous or serpiginous, slightly raised track. The diagnosis is mainly clinical, based on the history of travel to an endemic area and exposure to contaminated soil/sand and the characteristic serpiginous track. Treatment options as well as recent patents related to the management of cutaneous larva migrans are also discussed. Compared with oral antihelminthics, topical treatment over the affected area is less effective. Oral ivermectin is the treatment of choice.\n\n\nCONCLUSION\nThe pruritic serpiginous track is pathognomonic. Oral ivermectin is the treatment of choice.","PeriodicalId":20960,"journal":{"name":"Recent patents on inflammation & allergy drug discovery","volume":"11 1 1","pages":"2-11"},"PeriodicalIF":4.2000,"publicationDate":"2017-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"7","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Recent patents on inflammation & allergy drug discovery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1872213X11666170110162344","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 7

Abstract

BACKGROUND Cutaneous larva migrans is one of the most common skin diseases reported in travelers returning from tropical regions. Western physicians, however, are often not familiar of this condition. OBJECTIVE To review in depth the epidemiology, pathophysiology, clinical manifestations, complications, and treatment of cutaneous larva migrans. METHODS A PubMed search was completed in Clinical Queries using the key term "cutaneous larva migrans". The search included meta-analyses, randomized controlled trials, clinical trials, and reviews. Patents were searched using the key term "cutaneous larva migrans" from www.google.com/patents, www.uspto.gov, and www.freepatentsonline.com. RESULTS Cutaneous larva migrans is a zoonotic infestation caused by penetration and migration in the epidermis of filariform larva of different kinds of animal hookworms through contact with feces of infected animals. Cutaneous larva migrans is endemic in tropical and subtropical regions. Clinically, cutaneous larva migrans is characterized by an intensely pruritic erythematous migrating tortuous or serpiginous, slightly raised track. The diagnosis is mainly clinical, based on the history of travel to an endemic area and exposure to contaminated soil/sand and the characteristic serpiginous track. Treatment options as well as recent patents related to the management of cutaneous larva migrans are also discussed. Compared with oral antihelminthics, topical treatment over the affected area is less effective. Oral ivermectin is the treatment of choice. CONCLUSION The pruritic serpiginous track is pathognomonic. Oral ivermectin is the treatment of choice.
皮肤幼虫迁移。
背景:皮肤迁徙幼虫是热带旅行者中最常见的皮肤病之一。然而,西方医生往往不熟悉这种情况。目的综述皮肤迁徙幼虫的流行病学、病理生理、临床表现、并发症及治疗方法。方法在“临床查询”中使用关键词“皮肤迁移幼虫”完成PubMed检索。研究包括荟萃分析、随机对照试验、临床试验和综述。在www.google.com/patents、www.uspto.gov和www.freepatentsonline.com.RESULTSCutaneous中搜索关键词“皮肤幼虫迁移”进行专利检索,幼虫迁移是不同种类的动物钩虫丝状幼虫通过接触被感染动物的粪便,在表皮渗透迁移而引起的人畜共患疾病。皮肤幼虫迁徙是热带和亚热带地区的地方病。临床上,皮肤幼虫迁移的特征是强烈瘙痒的红斑性迁移,弯曲或蛇形,轻度凸起。诊断主要是临床诊断,根据流行地区旅行史和接触污染的土壤/沙子以及特有的蛇形足迹。治疗方案以及最近的专利有关的管理皮肤幼虫迁移也进行了讨论。与口服抗虫剂相比,局部治疗患处效果较差。口服伊维菌素是治疗的首选。结论瘙痒性蛇形道是典型的。口服伊维菌素是治疗的首选。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.90
自引率
0.00%
发文量
0
期刊介绍: Recent Patents on Inflammation & Allergy Drug Discovery publishes review articles by experts on recent patents in the field of inflammation and allergy drug discovery e.g. on novel bioactive compounds, analogs and targets. A selection of important and recent patents in the field is also included in the journal. The journal is essential reading for all researchers involved in inflammation and allergy drug design and discovery.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信